| 1888 Press Release | Technology News | Biotechnology News | Biotechnology RSS |  |
Latest Biotechnology News & Press Releases |
||
|
The Hamner Institutes For Health Sciences Sponsors Drug Safety Session At The 2008 Ced Biotech Conference
NC Event Expected To See More Than 800 Life Sciences Leaders. By Mmi Associates, Inc. - May 15, 2008 |
|
The Hamner Institutes For Health Sciences Researchers Present At 2008 Respiratory Drug Delivery Conference
Local Scientists Will Address New Research In Developing Nasal And Inhalation Drugs. By Mmi Associates, Inc. - May 09, 2008 |
|
TSSI Announces Five New Banking Customers For Deedmark™ Security Foil
Up to 455 million Chinese customers to be protected from counterfeiting and fraud. By Lighthousepr - April 25, 2008 |
|
The Hamner Institutes For Health Sciences Names Director Of Business And Technology Development
Dr. Naina Bhasin Joins Local Biomedical Research Institution. The Registry capitalized on advances in cell preservation and cell culture technology to make resected liver tissue available for use in biomedical research. By Mmi Associates, Inc. - April 23, 2008 |
|
Associate Director At Medimmune To Present At GTCbio’s 2nd Rediscovering Biomarkers Conference On July 10-11
Robert Lechleider, Associate Director at MedImmune to Present at GTCbio’s 2nd Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA By Gtcbio - April 21, 2008 |
|
Senior Research Scientist, Intrinsic Bioprobes To Present At GTCbio’s 2nd Rediscovering Biomarkers Conference On July 10-11, 2008 In Boston, MA
Urban Kiernan, Senior Research Scientist, Intrinsic Bioprobes to Present at GTCbio’s 2nd Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA By Gtcbio - April 20, 2008 |
|
Tim Harris Of Saic-frederick To Present At GTCbio’s 2nd Rediscovering Biomarkers Conference On July 10-11, 2008 In Boston, MA
Tim Harris, Director of Advanced Technology Program and Corporate VP of Technology at SAIC-Frederick to Present at GTCbio’s 2nd Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA By Gtcbio - April 20, 2008 |
|
Senior Director Of Technology Management At Roche To Present At GTCbio’s 2nd Rediscovering Biomarkers Conference On July 10-11
Thomas Li, Senior Director of Technology Management at Roche to Present at GTCbio’s 2nd Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA By Gtcbio - April 20, 2008 |
|
UNC -Chapel Hill, Hamner Institutes Announce Partnership To Accelerate Basic, Translational Research
The University of North Carolina at Chapel Hill and The Hamner Institutes for Health Sciences have signed a memorandum of understanding that will guide innovative collaborations in basic and translational research. By Mmi Associates, Inc. - April 19, 2008 |
|
Walter Carney To Present At GTCbio’s 2nd Rediscovering Biomarkers Conference On July 10-11, 2008 In Boston, MA
Walter Carney, Head of Oncogene Sciences at Siemens to Present at GTCbio’s 2nd Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA By Gtcbio - April 19, 2008 |
|
Victor Levenson Of Northwestern University To Present At GTCbio’s 2nd Rediscovering Biomarkers Conference On July 10-11, 2008 In Boston, MA
Victor Levenson, Director and Research Associate Professor, Robert H. Lurie Comprehensive Cancer Center at Northwestern University to Present at GTCbio’s 2nd Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA By Gtcbio - April 19, 2008 |
|
Saju Nettikadan To Present At GTCbio’s 2nd Rediscovering Biomarkers Conference On July 10-11
Saju Nettikadan, Director of Emerging Technologies at BioForce Nanosciences to Present at GTCbio’s 2nd Rediscovering Biomarkers Conference on July 10-11, 2008 in Boston, MA. By Gtcbio - April 19, 2008 |
|
Matthew Olson To Speak At GTCbio’s 3rd Assay Development & Screening Technologies Conference On June 5-6
Matthew Olson Principle Research Scientist at Johnson & Johnson to Speak at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA By Gtcbio - April 17, 2008 |
|
The Hamner Institutes For Health Sciences Hosts “Funding For Innovation In North Carolina” Workshop
SBIR/STTR Event Will Focus On $2 Billion Available For Innovative Start-ups By Mmi Associates, Inc. - April 16, 2008 |
|
Chris Austin To Give Keynote Presentation At GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6
Chris Austin, Director of the NIH Chemical Genomics Center to give Keynote Presentation at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA By Gtcbio - April 09, 2008 |
|
Hakim Djaballah, Director Of Hts At Memorial Sloan Kettering Cancer Center To Present At Gtcbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 In San Francisco, CA
Dr. Hakim Djaballah, Director of High Throughput Screening Core Facility at the Memorial Sloan Kettering Cancer Center will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. Dr. Djaballah will speak on successful applications of high content assays using confocal microscopy. By Gtcbio - April 03, 2008 |
|
John Cuozzo, Director Of ELT Lead Discovery At Glaxosmithkline To Present At GTCbio's 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 In San Francisco, CA
Dr. John W. Cuozzo, Director of ELT Lead Discovery at GlaxoSmithKline will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. Dr. Cuozzo will speak on selecting hits from billions of compounds from encoded library technology. By Gtcbio - April 03, 2008 |
|
Xi Chen To Present At GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6
Xi Chen, Assistant Professor at University of California, Davis to Present at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA By Gtcbio - April 03, 2008 |
|
Taosheng Chen To Present At GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6
Taosheng Chen, Director of HTS, St. Jude Children's Research Hospital to Present at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA By Gtcbio - April 03, 2008 |
|
Clay Scott Of Astrazeneca To Present At GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6
Clay Scott, Associate Director of Lead Generation at AstraZeneca to Present at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA By Gtcbio - April 03, 2008 |
|
Accelr8 And BD Agree On Terms For Technology Development Program For The BACcel Rapid Diagnostics Platform
Accelr8 Technology Corporation (Amex:AXK) announced today that BD (Becton, Dickinson and Company) and Accelr8 have agreed in principle to terms for an agreement with respect to Accelr8’s BACcel™ rapid bacterial diagnostic system. By Accelr8 Technology - April 02, 2008 |
|
Dr. Susan Taylor, Professor Of Pharmacology At UCSD To Give Featured Presentation At Gtcbio’s 3rd Protein Kinase In Drug Discovery Conference On May 5-6
Dr. Susan Taylor, Professor of Pharmacology at UCSD, will be giving the Featured Presentation at GTCbio’s 3rd Protein Kinase in Drug Discovery Conference on May 5-6, 2008 in San Diego, CA. By Gtcbio - March 29, 2008 |
|
Dr. Karim Dabbagh, Director Of Pharmacology At Roche To Present At Gtcbio’s 3rd Protein Kinase In Drug Discovery Conference On May 5-6
Dr. Karim Dabbagh the Director of Pharmacology at Hoffmann-La Roche will present at GTCbio’s 3rd Protein Kinase in Drug Discovery Conference on May 5-6, 2008 in San Diego, CA. By Gtcbio - March 29, 2008 |
|
Samuel H. Wood, CEO At Stemagen Will Give A Featured Presentation At The 4th International Stem Cell Research & Therapeutics
Samuel H. Wood, CEO at Stemagen, which announced on January 17, 2008 that it has become the first in the world to create, and meticulously document, a cloned human embryo using somatic cell nuclear transfer (SCNT), will give a featured presentation at the 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 in Boston, MA. By Gtcbio - March 27, 2008 |
|
Pfizer To Present At GTCbio’s 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 In Boston, MA
Mark Thiede of Pfizer will give a presentation entitled “Inference by Interference: Controlling MSC Differentiation with RNAi” at the 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 in Boston, MA. By Gtcbio - March 27, 2008 |
|
Jan Paul Medema, Professor Of Experimental Oncology And Radiobiology At The University Of Amsterdam To Present At Gtcbio’s 4th International Stem Cell Research & Therapeutics
Jan Paul Medema, Professor of Experimental Oncology and Radiobiology at the Academic Medical Center of the University of Amsterdam, will give a presentation at the 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 in Boston, MA. By Gtcbio - March 27, 2008 |
|
Senior Vice President Of Regenerative Medicine At Geron To Present At Gtcbio’s 4th International Stem Cell Research & Therapeutics, Apr 17- 18, 2008 In Boston, MA
Jane S. Lebkowski, Senior Vice President of Regenerative Medicine at Geron will give a presentation at the 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 in Boston, MA. By Gtcbio - March 27, 2008 |
|
President & Chief Executive Officer Of Sangamo Biosciences To Present At Gtcbio’s 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 In Boston, MA
Edward Lanphier, President & Chief Executive Officer at Sangamo BioSciences, which published a new study last October indicating that its technology could be used to modify the genomes in stem cells, create stem cell lines that mimic disease, and modify stem cells to treat diseases, will present at the 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 in Boston, MA. By Gtcbio - March 27, 2008 |
|
Senior Director At Genzyme To Present At GTCbio’s 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 In Boston, MA
Bruce Wentworth, Senior Director of Cardiovascular Research at Genzyme will give a presentation entitled “Retention of Cells after Transplantation” at the 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 in Boston, MA. By Gtcbio - March 27, 2008 |
|
Malcolm Moos, Medical Officer Of Division Of Cellular And Gene Therapies At FDA To Give Featured Presentation At The 4th International Stem Cell Research & Therapeutics
Malcolm Moos, Medical Officer of the Division of Cellular and Gene Therapies at the Food and Drug Administration (FDA) will give the featured presentation at the 4th International Stem Cell Research & Therapeutics, Apr 17-18, 2008 in Boston, MA. By Gtcbio - March 27, 2008 |
| 1 2 3 Next Last Page |
| Search |
| Search Press Release: |
| Bookmark Biotechnology RSS |
|
|
